With an aim to check whether aspirin can help stop the return of some cancers, a new clinical trial – largest of its kind – has been launched in the UK starting…
Tag: Clinical Trial
Personalized cellular therapy for leukemia yields promising results
The first of its kind personalized cellular therapy trial at University of Pennsylvania has yielded promising results with eight of 14 patients responding to the therapy, with some complete remissions continuing past…
Early antiretroviral therapy helps suppress HIV and prevents transmission
Researchers have concluded in a decade long clinical trail that early intervention could help suppress HIV as well as prevent its sexual transmission in heterosexual couples. The results of an international clinical…
Ebola drug trail stopped as TKM-Ebola-Guinea shows no overall benefit
Tekmira Pharmaceuticals Corporation has revealed that the Phase II clinical trial of its Ebola treatment TKM-Ebola-Guinea has reached a predefined statistical endpoint and that they have closed the enrollment indicating that the…
Early results of Bluebird Bio’s sickle cell disease therapy look promising
Bluebird Bio has revealed early safety and efficacy data based on long-term follow up of the first patient with severe sickle cell disease (SCD) treated with LentiGlobin BB305 product candidate in the…
Roche’s alectinib shows promise against ALK+ non-small cell lung cancer
Roche revealed positive results in two studies that investigated the capabilities of its oral investigational anaplastic lymphoma kinase inhibitor (ALKi) dubbed alectinib with the drub being able to shrink tumours in people…
Orexigen ends study of obesity drug Contrave
Orexigen Therapeutics along with its partner Takeda announced termination of the Light Study a cardiovascular (CV) outcomes trial of their obesity drug Contrave (naltrexone HCI and bupropion HCl extended-release tablets) after a…
Malaria vaccine candidate promising; could potentially prevent disease in millions
According to final clinical trial data published in The Lancet, the first malaria vaccine candidate (RTS,S/AS01) shows promise as it has proved partially effective against clinical disease in young African children up…